Treatment of Parkinson’s disease, secondary parkinsonism except drug-induced parkinsonism, Treatment and prophylaxis of infections induced by sensitive cultures of influenza A virus, Postherpetic neuralgia
Advertiser: AS “Olpha”
Information reviewed on 16.07.2024.
Prescription medicine. Complete summary of product characteristics see on www.zva.gov.lv. Information intended for healthcare specialists.